Significance and Innovations:
 Raynaud's phenomenon comprises a complex interplay of patient experiences that result in significant morbidity for patients living with systemic sclerosis  Our findings challenge the accepted paradigm of Raynaud's 'attacks' with not all systemic sclerosis patients identifying with this concept  Existing patient reported outcome instruments do not fully capture the patient experience of Raynaud's phenomenon in systemic sclerosis
The term Raynaud's phenomenon (RP) is generally used to describe episodic acral vasospasm manifesting as digital discolouration and pain (1) . The majority of people experiencing RP symptoms have primary RP; a syndrome of benign but intrusive exaggerated digital microvascular responses to cold and/or emotional stress, affecting approximately 5% of the healthy population (1, 2) . The term secondary RP is applied when the symptoms are the consequence of underlying pathology; an important cause being autoimmune rheumatic diseases such as systemic sclerosis (SSc), in which functional vascular disturbances are compounded by a progressive obliterative microangiopathy (1) . RP is the commonest diseasespecific manifestation of SSc affecting ~96% of patients (3) . SSc-RP is consistently ranked highest in patient surveys exploring the frequency and impact of disease-related complications of SSc (4, 5) . RP is an episodic phenomenon, not easily assessed in the clinic setting, leading to a reliance on patient-reported outcome (PRO) instruments. The patient perspective captured by PRO instruments provides valuable insight into the patient condition, not always captured by clinician-reported assessment tools (6) . However, no studies to date have explored the domains that form the patient perspective of SSc-RP; yet a thorough understanding of the patient experience of SSc-RP is essential if PRO instruments assessing the severity and impact of SSc-RP are to fully capture experiences important to patients (7) . The aim of the present study was to fully explore the themes and subthemes that comprise the patient experience of SSc-RP.
Patients & Methods

Study management
The study development and conduct was overseen by a steering committee comprising 9 SSc experts (JDP, RTD, LAS, TMF, NJM, AH, MMC, FI and DK), 2 patient research partners (JW and HJ), a vasculitis expert with experience in PRO instrument development (JR) and an experienced team of qualitative researchers (CA, ED and SH). Ethical approval was obtained from independent ethics committees by chief investigators at each patient-participating site (JDP, RTD and LAS respectively) with all participants providing informed consent before taking part.
Study design
An international multicentre qualitative research study comprising patient focus groups (FGs) in Bath (United Kingdom), Pittsburgh (United States of America) and New Orleans (United States of America) was developed to ensure experiences were sought from a broad geographical, cultural and ethnic cross-section of patients. Focus group (FG) meetings enable open discussion and debate amongst participants; allowing convergent and divergent views to be clarified where necessary during the discussion (8) . The dynamic nature of focus group interactions facilitates capture of patient experiences not always expressed in 1:1 interview settings.
Participants
All patients fulfilled the 2013 American College of Rheumatology/European League Against
Rheumatism classification criteria for SSc (9), were aged over 18 years, had sufficient English language skills to participate in group discussions and capacity to provide informed consent. Enrolment decisions were based on an a priori purposive sampling framework developed by the project steering committee and designed to ensure a representative patient cohort with respect to disease subtype (aiming for 60:40% split between limited and diffuse cutaneous SSc), disease duration with early and established disease (≤3 and >3 years since first non-RP symptom), history of digital ulcer disease (as a proxy for peripheral vascular disease severity, aiming for approximately 50:50% split to be representative of digital ulcer prevalence in SSc), gender (aiming for 5:1 female predominance) and ethnicity (with Caucasian, African-American and Hispanic representation). A clinician case-report form facilitated subsequent participant selection against the requirements of the purposive sampling framework (10) . The size of each FG was limited to a maximum of 9 participants to ensure all participants had the opportunity to express their personal views and could confidently challenge alternative/opposing experiences expressed within the group. A minimum of three FGs was originally planned with an intention to undertake additional FGs until 'thematic saturation' was achieved (11).
Data collection
Each FG lasted approximately one hour, was co-facilitated by JDP and at least 1 other member of the steering committee and was audio-recorded, transcribed and anonymised. An initial topic guide was developed by the steering committee (see supplementary material), with each FG commencing with broad open questions enquiring how patients would describe their RP experiences, before progressing to more focussed discussions, sometimes targeting incompletely explored emergent themes from earlier FGs, ensuring thematic saturation was achieved. At each FG, efforts were made to create a relaxed open environment in which the sharing of individual (and shared) experiences was encouraged and everybody's opinion respected.
Data analysis:
Qualitative analysis of the FG transcripts was undertaken by experienced qualitative researchers (SH, ED and CA). Inductive thematic analysis was adopted to ensure the findings were grounded in shared patient experiences rather than imposed from existing concepts (12) . In the first stage, qualitative data were coded by reading the anonymised transcript multiple times; making notes of words and short phrases that captured important experiences. Units of meaning were identified and given descriptive labels (codes). In the second stage, the codes from the transcript were reduced (removing duplications and merging overlapping codes) and explored to see how conceptually-related codes could be grouped to form subthemes, and finally subthemes were grouped to form overarching themes (12) . The themes were then independently and systematically applied to each transcript by other team members to ensure a rigorous analysis and minimise researcher bias (with amendments made if new codes emerged). This process was an iterative one, undertaken concurrently with data collection, allowing emerging themes to be explored and/or challenged in subsequent groups. After a preliminary independent analysis of the data, an analysis de-briefing meeting was convened attended by the qualitative research team (SH, CA and ED), SSc patient research partners (JW and HJ), an experienced PRO developer (JR) and SSc expert (JDP) to derive consensus on the theme groupings (and applicable subthemes) and the conceptual map describing the inter-relationship of the respective themes.
Results
Forty SSc patients participated in 6 focus groups conducted in Bath, UK (n=2), New Orleans, US (n=3) and Pittsburgh, US (n=1). The a priori purposive sampling framework ensured broad and representative participation in terms of clinical phenotype, age, gender and disease duration.
The multicentre design ensured diverse geographic, cultural and ethnic participation ( Table 1 ).
The composition of individual groups differed as deliberate efforts were made to include "missing cases" in the latter focus groups. A 7 th planned FG in Bath was cancelled as thematic saturation had been achieved. The physical symptoms of SSc-RP differed between participants (Table 2 ). For some, pain was the predominant sensation (Q1-2), whereas others described the predominant symptoms as numbness and/or tingling (Q3-4) or even burning/stinging/hypersensitivity (Q5-6). Many patients reported a combination of symptoms (Q7), sometimes evolving as episodes of digital ischaemia develop and abate. Patients are aware that their peripheries are cold to touch and many patients associate physical symptoms of pain and numbness as "feeling cold" (Q8-9). A combination of pain and altered tactile sensation result in difficulty using the hands (Q10-11), particularly concerning fine motor function (Q10) which can be further impaired by the need to wear gloves (Q60). The oft-cited "red, white and blue" digital colour changes of SSc-RP were described, as expected, but patients preferentially adopted other terms such as purple (Q13 and Q15), marbling (Q12) and black to report the cutaneous discolouration of SSc-RP (Q7 and Q14).
The fingers are the predominant body site considered by patients when discussing SSc-RP, in part because the fingers are the most significantly affected area (Q15), but also owing to the importance of the fingers for activities of daily living and the fact that the fingers (unlike the toes, nose and lips) are typically exposed; both to the elements and the visible attention of the patient (Q16). Discolouration of the knees, not a body site usually associated with SSc-RP, was mentioned by more than one participant (Q15). Colour changes in the lips, nose and knees do not appear to result in the same sensory changes as the fingers and toes. For many participants, the notion of "attacks" was consistent with their experiences of SSc-RP but some expressed difficulty distinguishing "attacks" of SSc-RP as the following passage attests: The duration of SSc-RP attacks differed between individuals and varied within individual patients according to exposure to cold and the capacity of patients to either take positive steps to warm their hands or extract themselves from an environment conducive to SSc-RP symptoms (Q17-18). The frequency of SSc-RP attacks was also largely dependent on exposure to exacerbating triggers but the majority reported attacks occurring several times per day and seldom experienced days completely free of SSc-RP symptoms (Q19).
Theme 2: Emotional impact of SSc-RP Experiences of SSc-RP have a significant emotional impact on patients encompassing feelings of distress (Q20), annoyance (Q21-23) and, for some, desperation (Q24) ( Table 2 ). Loss of normality and the restrictive nature of SSc-RP on social participation and leisure pursuits is a particular source of frustration. For some, emotional distress resulted in irritability that impacts on relationships (see later). Unwanted attention towards cutaneous discolouration, the need to wear extra clothing/gloves in ambient conditions and difficulty using hands due to SSc-RP, was highlighted as a source of embarrassment, particularly in the workplace and/or public places (Q25-28). Actual body image dissatisfaction related to the visible discolouration of SSc-RP was not a common theme and many patients had come to accept the appearance of SSc-RP (Q42, see later).
Theme 3: Triggers and exacerbating factors
Cold exposure was the principal exacerbating factor for all participants (Table 3) . Defining a temperature threshold at which RP attacks were more likely was volunteered by some participants (Q29), whereas for most it was a change (typically a reduction) in temperature or draught that was most likely to precipitate SSc-RP symptoms (Q30-31). Exposure to domestic refrigeration appliances (Q32-34) and air conditioning were very frequent exacerbating factors, with visits to the grocery store being particularly likely to trigger SSc-RP symptoms (Q32-34), perhaps owing to less easily mitigated sporadic fluctuations in temperature that grocery shopping results in. For many, emotional stress was an important trigger (Q35-36), sometimes exacerbated by feelings of embarrassment caused by digital discolouration (Q25), and some patients reported their SSc-RP symptoms were less intrusive and more manageable when they felt relaxed (Q37). For others, and in contrast to cold exposure, stress had no discernible impact on their SSc-RP (Q38). Some participants reported a high level of unpredictability, with SSc-RP attacks occurring for no apparent reason (Q39). Rarely reported exacerbating factors included gripping tightly and passive smoke inhalation.
Theme 4: Constant vigilance & self-management
Patients described a life of constant vigilance and self-management that, for patients, means that nothing is simple anymore and everything must be planned and prepared for. All patients reported taking positive steps to maintain warmth to prevent and/or reduce the impact of SSc-RP (Q40-42, Table 3 ) and patients reported such behaviour helping them manage their symptoms better as time had progressed (Q43). Abating attacks of SSc-RP necessitates the application of local warmth and many patients reported strategies they had adopted to achieve this such as using heat packs, submerging in basin of warm water etc. (Q44-47). Patients with SSc make significant sacrifices to avoid cold exposure that, whilst helpful, negatively influence social participation, relationships and leisure activities (Q48-50). Despite the adoption of such measures, complete avoidance of SSc-RP symptoms was an unachievable goal and many participants accepted the limits of self-management (Q51-55).
Theme 5: Impact on daily life
Each of the preceding themes make their own specific contribution to the broader impact of SSc-RP on daily life (evident from a number of quotations provided in Tables 2 and 3 ). Specific aspects of daily life that are commonly affected include shopping (Q56), household chores (Q57-58) and self-care (Q59). The need to wear gloves the majority of time exacerbates the impaired functional capacity making everyday activities harder to complete (Q60). Participation and enjoyment in social and leisure activities are either directly affected by SSc-RP symptoms (Q61-64) or lead to trade-offs taken to avoid cold exposure (Q50). Participants provided examples when work participation was challenging because of an inability to control their work environment to suit their needs (Q65). An inability to complete work tasks due to SSc-RP was a source of guilt for some (Q66-67). Some reported negative experiences in the workplace from colleagues ignorant or unsympathetic to their needs (Q68) whilst other expressed concerns about the effect of SSc-RP on job security (Q69). Several examples were given of the impact of SSc-RP on family life, which included being irritable around family members (Q70-71), having difficulty fulfilling family roles (Q72-73) and a sense that family members don't fully appreciate the extent of their problems (Q74). Many participants expressed sorrow relating to a loss of normality and inability to do things they took for granted previously (Q75).
Theme 6: Uncertainty
All of the preceding themes result in having to manage a life that is filled with uncertainty. This broad-ranging theme encompassed a number of aspects relevant to SSc-RP ranging from the aforementioned uncertainty over the labels we use to describe "attacks" of SSc-RP , uncertainty regarding future disease progression (particularly concerning the development of digital ulcers in patients with prior experience of this complication, Q76-78), the relevance of SSc-RP symptoms on the aging process (Q79) and/or uncertainty regarding the likely efficacy of current/future drug treatments for controlling their SSc-RP (Q80). A change in routine can provoke uncertainty and anxiety regarding the likely impact on the participants' ability to manage their SSc-RP symptoms (Q81-82). Indeed, a generalised anxiety surrounding finding themselves in an environment in which their symptoms were poorly controlled and the need to make adequate preparation for activities that might impact on SSc-RP symptoms was a recurring theme across the focus groups (Q83-84).
Theme 7: Adaptation
In spite of all the aforementioned unpleasant experiences and challenges, participants reported many examples that demonstrated a remarkable capacity to adapt to life with SSc-RP. Examples included adaptations made in the home environment (Q85), trade-offs accepted in daily activities and social participation (Q86-89) and scenarios in which they might seek help from others (Q90). Acceptance of the need to continue life despite SSc-RP, supported by a strong sense of "not letting it beat you", emerged within each FG, and a number of quotations highlight the resilience and fortitude with which many patients face their illness (Q91-94).
Discussion
We report the outcome of the first study to specifically examine the patient experience of SSc-RP. The multi-centre design and comprehensive purposive sampling framework has ensured we have captured experiences from a representative cohort of SSc patients in terms of age, gender, disease duration and clinical phenotype; whilst also ensuring diverse geographic, cultural and ethnic participation. Thematic analysis of the anonymised FG transcripts was led by qualitative researchers without direct experience of managing SSc, ensuring an unbiased appraisal of the experiences expressed. The involvement of patient research partners in decision-making has ensured each stage of the study (from devising the FG topic guide to the interpretation of thematic analysis) was appropriate and suitable for achieving the project's stated aims. We chose FGs over individual patient interviews to allow participants to respond to the opinions of others; challenging and/or validating the views of other group members. FGs can result in a propensity for participants to conform to majority opinion but deliberate efforts were made to create an environment that avoided this. We feel the FGs facilitated the capture of relevant and generalizable experiences across the diverse spectrum of SSc, which might not have emerged from 1:1 patient interviews.
Inductive thematic analysis has identified 7 major inter-related themes (and encompassing subthemes) that constitute the patient experience of SSc-RP that can be arranged within a conceptual map of SSc-RP. Unsurprisingly, the physical symptoms of SSc-RP are positioned at the heart of our conceptual map and featured prominently when participants were asked to describe their RP experiences. Specific physical symptoms of SSc-RP differed between patients with some experiencing a predominance of pain, whereas for others numbness was a more relevant description of their experiences of SSc-RP. The physical symptoms of SSc-RP lead to considerable emotional distress, and impaired ability to use the hands results in significant impact on daily life. Cold exposure is the major trigger for SSc-RP symptoms, although many participants also reported emotional stress as an exacerbating factor. People with SSc take considerable measures to avoid or ameliorate SSc-RP symptoms but self-management approaches are seldom completely effective and can directly impact on functional capacity, social participation and quality of life. Patients adapt over time, developing strategies that increase resilience and help them to carry on life despite SSc-RP, although for many, SSc-RP symptoms contribute to a pervading uncertainty for the future progression of their disease and general well-being.
Our findings have implications for current approaches to assessing SSc-RP. The episodic nature of SSc-RP has resulted in a reliance on patient self-report. Early therapeutic studies of SSc-RP sought a categorical assessment of SSc-RP severity (typically; "better", "same" or "worse") (13) (14) (15) (16) ). These were gradually superseded by linear psychometric scales allowing quantification of specific components of SSc-RP symptoms such as pain intensity and the severity of attacks (17- The present work has revealed limitations to current methods for assessing SSc-RP. Firstly, our findings challenge the accepted paradigm of Raynaud's "attacks" with not all patients identifying with this concept. For many, SSc-RP represents a more nebulous concept that encompasses experiences across several of the themes defined in this work. Moreover, diary monitoring of SSc-RP attack frequency and duration makes no allowance for the considerable measures patients take on a daily basis to prevent or ameliorate symptoms of SSc-RP (themes 4 and 6). In this regard, diary monitoring more accurately provides a combined assessment of peripheral microvascular compromise in conjunction with the effectiveness of self-management approaches adopted by patients to control their symptoms. The RCS, meanwhile, attempts to capture the complex multi-domain construct of SSc-RP in a single item global assessment. This approach risks missing clinically important improvements in individual domains (e.g. pain) as respondents are forced to consider the impact of other domains that might be more resistant to intervention. The item wording ("how much difficulty") might be influenced by habituation and adaption (themes 4 and 6), whereas the inclusion of "painful sores" in the originally validated RCS might result in inadvertent assessment of digital ulcer disease. These limitations might offer some explanation for the poor agreement between RCS diary returns and objective assessments of peripheral microvascular function in SSc (31). Similarly, the SHAQ RP VAS item wording ("interfered with your activities") might also be influenced by self-management and adaption (themes 4 and 6). Existing PRO instruments do not capture frequently expressed physical symptoms of SSc-RP such as "tingling" and "hypersensitivity" of the fingertips or "feeling cold", whereas other important physical symptoms such as pain and numbness might be better assessed in isolation. Emotional distress (theme 2) and the impact of SSc-RP on social participation, family life and work (theme 5) are not captured using existing tools, despite such themes emerging prominently in this study. Additional concerns have been raised regarding existing methods for assessing SSc-RP (e.g. placebo effect and respondent burden) and there is consensus that novel approaches to assessing SSc-RP are required (32).
There was little patient participation in the development of existing PRO instruments for SSc-RP (33). Regulatory bodies now seek target patient population involvement in PRO instrument design when examining labelling claims in medical product development (7) and patient involvement ensures the capture of experiences relevant to the patient in a comprehensible and unambiguous manner (34). Work to develop a novel patient-derived PRO instrument for assessing the severity and impact of SSc-RP, comprising domains/items grounded in the patient experiences of SSc-RP identified in this work is currently underway. (88) 2 (12) 5 (83) 1 (17) 4 (24) 13 (76) 24 (60) 16 (40) Disease duration*, n (%): ≤3 years >3 years 2 (12) 15 (88) 2 (33) 4 (67) 5 (29) 12 (71) 9 (23) 31 (77) Gender, n (%):
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16 (94) 1 (6) 5 (83) 1 (17) 13 (76) 4 (24) 34 (85) (59) 4 (33) 2 (67) 12 (71) 5 (29) 23 (58) 17 (42) Figure 1 . A conceptual map comprising the 7 major inter-related themes that constitute the patient experience of SSc-RP. Table 2 . Quotes supporting the "Physical Symptoms" and "Emotional Impact" themes of the patient experience of SSc-RP Q refers to the numbered quote cited in the text. P1 denotes Pittsburgh, group 1; N1, N2, N3 denotes New Orleans groups 1, 2, and 3, respectively; B1, B2 denotes Bath groups 1 and 2; S# denotes subject (participant) number within each focus group.
Subtheme
Q Subject Quotation
Physical symptoms of SSc-RP Pain 1 P1 S2: How do I feel when it happens? Oh, my fingers start to hurt, they turn white, and it hurts not only on the surface but all the way down to the bone 2 P1 S5: When you say the word Raynaud's, I just think the word pain. Numbness/ Tingling 3 B2 S1: I have tingling at times but it's the numbness and not being able to feel and touch I think is the main thing, really from the symptom point of view as opposed to what it looks like. 4 P1 S6: They get very numb. It's not exactly pain, it's like that really, really deep numbness, like it almost hurts, but to me it's not exactly the same as pain. Burning/ hypersensitivity 5 N1 S4: I think stinging, the stinging sensation that you feel whenever something like your leg falls asleep or something, I will get that sensation 6 N1 S6: …they were so sensitive, so tender, the fingertips. I did have an office job so I did a lot of typing, and I actually could not … type like you normally type. 7 B1 S6: … a loss of sensation and then I get severe tingling, pain and then black hands, would be the quick way of describing it. Feeling cold 8 N1 S2: I would describe it as your hands are extremely cold 9 B1 S3: …my hands and my feet go like, well they're like ice. I can't even touch myself when I get a bad attack of it. I can't put my hand on my arm, I'm so cold Difficulty using hands 10 B1 S2: ..when the sensation kicks in you can't, you can't pick things up and you can't knit or get the money out of your purse… 11 N3 S2: When you're going through a serious episode of Raynaud's you're hands are pretty much useless to you Colour changes
12
B1 S1: In those days it was very much marbling. Now it is straight to the white. I have mittens all over my house. I have great friends who knit me mittens and so I go to the grocery store with mittens on. People look at me like I'm really dumb, but that's life. Who cares if they think I'm dumb wearing mittens, but they work. 43 P1 S1:
The first 5-10 years [were] really rough, and I was stubborn. I just wanted to wear a t-shirt and a jacket and some gloves, and you have to accept, no, I need to have a t-shirt, a longer shirt and a hoodie and a jacket and mittens, and everyone else is wearing some lighter clothes and I'm there totally bundled up, but at this point that's kind of just my daily life, so I think it's actually gotten easier over time. Seeking warmth (alleviating measure) 44 N3 S2: If it sets in just putting a glove on, putting gloves on, just won't do it….I have to put heat to my hands somehow with something, to apply heat to get that pain to go away. 45 P1 S1: Like everyone's said they'll pretty much stay that colour until I do something; run them under hot water or put some gloves on or put a jacket on, especially in the grocery store, I notice that all the time. 46 N3 S1: Oh no, you'd have to do something in order to warm them up, and you can't just, like when your fingers or hands go numb, you shake them out, it's not a shake it out kind of scenario, it's a 'I got to do something.' 47 B1 S5: Well one thing that is quite easy I find is a wash basin of warm water, you know, in an emergency if you've obviously got nothing else…..It comes back you know, all right I find. Avoiding cold 48 B1 S4: I tend not to leave the house if I don't have to in the winter 49 P1 S6:
My brother lives in xx and I just won't visit him unless it's like the height of summer because it's freezing up there and there's nothing I can do to get warm enough so I just don't go there. 50 P1 S4:
I don't ski anymore, either…'cos you're taking your gloves off, if your ski falls off or whatever, so even if you have something in your gloves to keep them warm, no, so I avoid winter activities, let's put it that way. Limited effectivene ss of selfmanageme nt 51 B1 S2: I had three pairs of gloves on the other day and I'd still got cold hands 52 P1 S3:
I think I could possibly prevent attacks all day, but nobody would be able to live with me [if I maintained] the house at 90 degrees [°F] . (laughter) 53 B2 S5: I find that there's nothing you can do to stop the attack because with me there's no tell-tale sign, there's no tingling, it's just I'm here and you're gonna (sic) have to deal with it, whether it takes ten minutes, twenty minutes it is as long as it lasts. 54 P1 S2:
I can't prevent them, but as soon as they [SSc-RP symptoms] start I try to do something about it, try to warm them up 55 B2 S4: The best thing is to get out the environment that's causing it but you can't always do that, you know so at that stage there is no hope.  Thank participants for their time and input to the discussion  Issue participants with pack containing 14 day RCS diary and subsequent questionnaire. Tutor participants on completion of these.
